FDA Briefing Docs Offer Positives and Negatives for Sarepta (SRPT) - Baird
Go back to FDA Briefing Docs Offer Positives and Negatives for Sarepta (SRPT) - Baird| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 56.50 +0.60 (1.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.90 | 52 Week High | $108.96 | |||
| Open | $55.80 | 52 Week Low | $62.12 | |||
| Day High | $57.00 | P/E | N/A | |||
| Day Low | $55.74 | EPS | $-1.27 | |||
| Volume | 1,981,669 | |||||
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 17.26 -0.39 (2.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.65 | 52 Week High | $63.73 | |||
| Open | $17.33 | 52 Week Low | $8.00 | |||
| Day High | $17.80 | P/E | N/A | |||
| Day Low | $17.22 | EPS | $-5.69 | |||
| Volume | 2,254,961 | |||||
